Pillar Biosciences welcomes new independent board member Robert Forrester
Natick, MA, Oct 1, 2020 — Pillar Biosciences, a next-generation sequencing (NGS) clinical cancer diagnostics company, today announced the addition of a new independent board member, Robert Forrester. Mr. Forrester has over two decades of experience in C-level positions in the pharmaceutical industry. Mr. Forrester joins a team of pragmatic experts in diagnostics and oncology […]